UiPath Inc. (NYSE:PATH) Shares Sold by Princeton Capital Management LLC

Princeton Capital Management LLC lessened its position in UiPath Inc. (NYSE:PATH) by 23.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 21,267 shares of the company’s stock after selling 6,588 shares during the period. Princeton Capital Management LLC’s holdings in UiPath were worth $270,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of the company. Smartleaf Asset Management LLC grew its stake in shares of UiPath by 88.5% in the fourth quarter. Smartleaf Asset Management LLC now owns 2,454 shares of the company’s stock worth $31,000 after purchasing an additional 1,152 shares in the last quarter. First Horizon Advisors Inc. lifted its holdings in UiPath by 47.8% in the fourth quarter. First Horizon Advisors Inc. now owns 2,487 shares of the company’s stock worth $32,000 after purchasing an additional 804 shares during the period. EverSource Wealth Advisors LLC grew its position in UiPath by 141.4% in the 4th quarter. EverSource Wealth Advisors LLC now owns 2,974 shares of the company’s stock valued at $38,000 after buying an additional 1,742 shares in the last quarter. V Square Quantitative Management LLC increased its stake in UiPath by 33.4% during the 4th quarter. V Square Quantitative Management LLC now owns 3,030 shares of the company’s stock valued at $39,000 after buying an additional 759 shares during the period. Finally, Quarry LP raised its position in shares of UiPath by 654.4% during the 3rd quarter. Quarry LP now owns 3,146 shares of the company’s stock worth $40,000 after buying an additional 2,729 shares in the last quarter. 62.50% of the stock is currently owned by institutional investors.

Insider Activity

In other UiPath news, CFO Ashim Gupta sold 47,227 shares of the stock in a transaction on Friday, January 3rd. The shares were sold at an average price of $13.06, for a total value of $616,784.62. Following the completion of the sale, the chief financial officer now directly owns 856,538 shares of the company’s stock, valued at $11,186,386.28. This represents a 5.23 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CAO Hitesh Ramani sold 25,000 shares of the business’s stock in a transaction dated Friday, January 3rd. The stock was sold at an average price of $13.05, for a total transaction of $326,250.00. Following the transaction, the chief accounting officer now owns 269,421 shares in the company, valued at approximately $3,515,944.05. The trade was a 8.49 % decrease in their position. The disclosure for this sale can be found here. 22.37% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

PATH has been the topic of several research reports. Morgan Stanley dropped their price target on shares of UiPath from $16.00 to $12.00 and set an “equal weight” rating on the stock in a research report on Thursday, March 13th. JPMorgan Chase & Co. raised their target price on shares of UiPath from $17.00 to $18.00 and gave the stock an “overweight” rating in a report on Friday, December 6th. Evercore ISI decreased their price target on shares of UiPath from $16.00 to $12.00 and set an “in-line” rating on the stock in a research report on Thursday, March 13th. BMO Capital Markets cut their price objective on UiPath from $16.00 to $11.50 and set a “market perform” rating for the company in a research report on Friday, March 14th. Finally, Canaccord Genuity Group reduced their price objective on UiPath from $19.00 to $14.00 and set a “buy” rating for the company in a research note on Thursday, March 13th. Two research analysts have rated the stock with a sell rating, fifteen have issued a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $13.62.

UiPath Price Performance

NYSE PATH opened at $11.20 on Tuesday. UiPath Inc. has a fifty-two week low of $9.50 and a fifty-two week high of $23.35. The stock’s 50-day moving average is $13.07 and its two-hundred day moving average is $13.07. The firm has a market cap of $6.15 billion, a P/E ratio of -69.97 and a beta of 1.00.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.